Managing Diabetes to Gain Opportunities for a More Active Life
Not Applicable
Completed
- Conditions
- Diabetes Mellitus, Type 2
- Interventions
- Behavioral: My Diabetes Goal Survey and Optional Care Management
- First Posted Date
- 2018-10-02
- Last Posted Date
- 2023-02-21
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 110
- Registration Number
- NCT03692208
- Locations
- 🇺🇸
University of Chicago, Chicago, Illinois, United States
Study of Drug 1 (Enzalutamide) Plus Drug 2 (Relacorilant) for Patients With Prostate Cancer
Phase 1
Active, not recruiting
- Conditions
- Prostate Cancer
- Interventions
- First Posted Date
- 2018-09-18
- Last Posted Date
- 2024-07-31
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 35
- Registration Number
- NCT03674814
- Locations
- 🇺🇸
University Of Chicago Medicine Comprehensive Cancer Center, Chicago, Illinois, United States
CASH (Cavernous Angiomas With Symptomatic Hemorrhage) Trial Readiness
Completed
- Conditions
- Cavernous AngiomaCavernomaCerebral Cavernous MalformationCCMCerebral Cavernous Malformations 1Cerebral Cavernous Malformations 3Cerebral Cavernous Malformations 2
- First Posted Date
- 2018-08-29
- Last Posted Date
- 2024-06-27
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 123
- Registration Number
- NCT03652181
- Locations
- 🇺🇸
The University of Chicago Medical Center, Chicago, Illinois, United States
Behavioral Chronotype: Impact on Sleep and Metabolism
Not Applicable
Active, not recruiting
- Conditions
- Cardiovascular DiseasesType2 Diabetes Mellitus
- Interventions
- Behavioral: Extended Overnight FastBehavioral: Late Total Caloric IntakeBehavioral: Early Total Caloric Intake
- First Posted Date
- 2018-08-27
- Last Posted Date
- 2025-05-06
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 200
- Registration Number
- NCT03647306
- Locations
- 🇺🇸
University of Chicago, Chicago, Illinois, United States
Study to Develop Head Stabilizer for Use During Brain Radiation Therapy
Not Applicable
Withdrawn
- Conditions
- Brain CancerBrain Diseases
- Interventions
- Device: Wiersma Head StabilizerDevice: AlignRT system
- First Posted Date
- 2018-08-14
- Last Posted Date
- 2020-05-08
- Lead Sponsor
- University of Chicago
- Registration Number
- NCT03629964
- Locations
- 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States
Supportive Release Center Study
Not Applicable
Active, not recruiting
- Conditions
- Mental HealthMental Health ServicesSubstance UseContinuity of Patient CareRecidivism
- Interventions
- Behavioral: TASC Service Linkages - Discharge Area OnlyBehavioral: SRC Overnight StayBehavioral: TASC Services Linkages - SRC OnsiteBehavioral: APN Appointment
- First Posted Date
- 2018-08-06
- Last Posted Date
- 2025-04-11
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 15195
- Registration Number
- NCT03616990
- Locations
- 🇺🇸
Cook County Department of Corrections & SRC, Chicago, Illinois, United States
Pembrolizumab and EDP1503 in Advanced Melanoma
Phase 2
Active, not recruiting
- Conditions
- Melanoma (Skin)Melanoma
- Interventions
- Biological: EDP1503
- First Posted Date
- 2018-07-23
- Last Posted Date
- 2024-07-31
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 8
- Registration Number
- NCT03595683
- Locations
- 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States
An Early Real-Time Electronic Health Record Risk Algorithm for the Prevention and Treatment of Acute Kidney Injury
Not Applicable
Recruiting
- Conditions
- Acute Kidney Injury
- Interventions
- Other: Standard of Care (SOC)Other: Early Nephrology Consult (ENC)
- First Posted Date
- 2018-07-18
- Last Posted Date
- 2024-08-06
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 180
- Registration Number
- NCT03590028
- Locations
- 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States
Developing an Imaging-Based Tool to Identify Areas for Prostate Cancer Biopsy
Not Applicable
Recruiting
- Conditions
- Prostate Cancer
- Interventions
- Procedure: Diagnostic MRIProcedure: Diagnostic Prostate BiopsyDevice: Risk Map DSS tool
- First Posted Date
- 2018-07-13
- Last Posted Date
- 2023-08-25
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 100
- Registration Number
- NCT03585660
- Locations
- 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States
Rucaparib and Nivolumab in Patients With Prostate or Endometrial Cancer
Phase 1
Terminated
- Conditions
- Endometrial CancerProstate Cancer
- Interventions
- First Posted Date
- 2018-06-28
- Last Posted Date
- 2021-03-09
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 12
- Registration Number
- NCT03572478
- Locations
- 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States
© Copyright 2025. All Rights Reserved by MedPath